All dedicated to ambitious Clinical Research

Based in Germany, in the heart of Europe, CRS runs four research units with more than 200 clinical pharmacological beds.

All CRS clinics are based in metropolitan areas. The respective German „Bundesländer“ (Federal States) represent ca. 35 million inhabitants. Accessibility to several million people is one of the basics for effective recruitment of patients, healthy volunteers or symptom bearing subjects, a prerequisite for the conduct of large scale, long-standing clinical trials and early proof of concept.


Our Clinical Pharmacology Unit Specialized In Women’s Health Trials

A major scope of the CRS Berlin team is the simultaneous conduct of in-house and outpatients early phase clinical trials in the field of women’s health with solid expertise in a wide range of trial designs.



Top Recruiter of Hepatic and Renal Impaired Patients for Clinical Trials

CRS early phase clinical trial unit in Kiel is a world’s top recruiter for patients with hepatic and renal impairment; yet it has transferred its experience into other therapeutic areas.


Exceptional Expertise in Cardiometabolic Phase I/II Clinical Trials Largest Phase I/II Clinic

CRS Mannheim has a long-standing track record in the entire spectrum of phase I and II clinical trial challenges with exceptional expertise in cardiometabolics, while always adhering to the highest quality standards.


Expert in Trials on Metabolic, Hematologic and Cardiovascular Diseases

CRS Wuppertal’s core competence is the conduct of phase I clinical trials with complex trial designs, various types of drug applications, coupled with multiple bioanalytical sample preparations.